Evaluation of an auto-CPAP device for treatment of obstructive sleep apnoea

Thorax

Volumn 53, Issue 8, 1998, Pages 643-648

  Ficker, J H ^a   Wiest, G H ^a   Lehnert, G ^a   Wiest, B ^a   Hahn, E G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Automatic; Nasal continuous positive airway pressure; Obstructive sleep apnoea

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; FEMALE; HUMAN; MALE; POSITIVE END EXPIRATORY PRESSURE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; SLEEP PATTERN; TREATMENT OUTCOME; VENTILATOR;

EID: 0031819592     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.8.643     Document Type: Article

References (29)

1. Sullivan CE, Issa FG, Berthon Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981;i;862-5.
2. Strollo PJ Jr, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996;334:99-104.
3. Strohl KP, Redline S. Nasal CPAP therapy, upper airway muscle activation, and obstructive sleep apnea. Am Rev Respir Dis 1986;134:555-8.
4. American Thoracic Society. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 1994;150:1738-45.
5. Waldhorn RE, Herrick TW, Nguyen MC, et al. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990;97:33-8.
6. Hoffstein V, Viner S, Mateika S, et al. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992;145:841-5.
7. Ficker JH, Müller D, Wiest G, et al. Nasale CPAP-Therapie des obstruktiven Schlafapnoe-Syndroms mit exspiratorischer Druckreduktion: Eine prospektive randomisierte Untersuchung zur Akzeptanz der Behandlung während der Therapieeinleitung. Pncumologic 1997;51:586-91.
8. Kribbs NB, Pack AI, Kline LR, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993;147: 887-95.
9. Reeves-Hoche MK, Hudgel DW, Meek R, et al. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:443-9.
10. Sanders MH, Gruendl CA, Rogers RM. Patient compliance with nasal CPAP therapy for sleep apnea. Chest 1986;90: 330-3.
11. Polo O, Berthon Jones M, Douglas NJ, et al. Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994;344:656-60.
12. Series F, Marc I, Cormier Y, et al. Required levels of nasal continuous positive airway pressure during treatment of obstructive sleep apnoea. Eur Respir J 1994;7:1776-81.
13. Issa FG, Sullivan CE. Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 1984;57:520-7.
14. Meurice JC, Marc I, Series F. Efficacy of auto-CPAP in the treatment of obstructive sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1996;153:794-8.
15. Grunstein RR. Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax 1995;50:1106-13.
16. Condos R, Norman RG, Krishnasamy I, et al. Flow limitation as a noninvasive assessment of residual upper- airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med 1994;150:475-80.
17. Lofaso F, Lorino AM, Duizabo D, et al. Evaluation of an auto-nCPAP device based on snoring detection. Eur Respir J 1996;9:1795-800.
18. Ficker JH, Wiest G, Lehnert G, et al. "Auto-CPAP"-Therapie des obstruktiven Schlafapnoe-Syndroms: Eine prospektive randomisierte Untersuchung während der Therapiecinleitung. Dtsch med Wochenschr 1997;48:1482-8.
19. Berthon Jones M. Feasibility of a self-setting CPAP machine. Sleep 1993;16:S120-3.
20. American Thoracic Society. Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989; 139:559-68.
21. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, US Government Printing, 1968: 1-12.
22. Bonnet M, Carley D, Carskadon MA. EEG arousals: scoring rules and examples. Sleep 1992;15:174-84.
23. Stradling JR, Barbour C, Pitson DJ, et al. Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes. Thorax 1997;52:72-5.
24. Quatember R, Maly J. Neuropsychologische Untersuchungsmethoden altersspezifischer Leistungsparameter. Wien Med Wochenschr 1980;130:688-92.
25. Hofmann G, Klein HE. Der Vigilanztest nach Quatember und Maly als diagnostisches Hilfsmittel bei Schlafapnoe. In: Meier-Ewert K, Rüther E, eds. Schlafmedizin. Stuttgart, Jena, New York: Gustav Fischer Verlag, 1993: 272-3.
26. Sturm W, Buessing A. Normierungs- und Reliabilitatsuntersuchungen zum Vigilanzgerat nach Quatember und Maly. Diagnostica 1990;36:50-9.
27. Johns MW. A new method for measuring daytime sleepiness: The Epworth Sleepiness Scale. Sleep 1991;14: 540-5.
28. Hardinge FM, Pitson DJ, Stradling JR. Use of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea. Respir Med 1995;89:617-20.
29. Meyer TJ, Eveloff SE, Kline LR, et al. One negative polysomnogram does not exclude obstructive sleep apnea. Chest 1993;103:756-60.